Gregory T Went - Net Worth and Insider Trading
Gregory T Went Net Worth
The estimated net worth of Gregory T Went is at least $3 Million dollars as of 2024-05-14. Gregory T Went is the CEO of Adamas Pharmaceuticals Inc and owns about 375,533 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $3 Million. Details can be seen in Gregory T Went's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory T Went has not made any transactions after 2019-03-20 and currently still holds the listed stock(s).
Transaction Summary of Gregory T Went
Gregory T Went Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory T Went owns 1 companies in total, including Adamas Pharmaceuticals Inc (ADMS) .
Click here to see the complete history of Gregory T Went’s form 4 insider trades.
Insider Ownership Summary of Gregory T Went
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ADMS | Adamas Pharmaceuticals Inc | 2019-04-08 | director & Chief Executive Officer |
Gregory T Went Latest Holdings Summary
Gregory T Went currently owns a total of 1 stock. Gregory T Went owns 375,533 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 20, 2019, with a value of $3 Million.
Latest Holdings of Gregory T Went
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ADMS | Adamas Pharmaceuticals Inc | 2019-03-20 | 375,533 | 8.22 | 3,086,881 |
Holding Weightings of Gregory T Went
Gregory T Went Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory T Went has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 6,319 shares on March 20, 2019, which brought Gregory T Went around $50,489.
Insider Trading History of Gregory T Went
- 1
Gregory T Went Trading Performance
GuruFocus tracks the stock performance after each of Gregory T Went's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory T Went is -31.39%. GuruFocus also compares Gregory T Went's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory T Went within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory T Went's insider trading performs compared to the benchmark.
Performance of Gregory T Went
Gregory T Went Ownership Network
Ownership Network List of Gregory T Went
Ownership Network Relation of Gregory T Went
Gregory T Went Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
Gregory T Went is the director & Chief Executive Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
Gregory T Went Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory T Went. You might contact Gregory T Went via mailing address: C/o Adamas Pharmaceuticals, Inc. 2200 Powell St, Ste 220 Emeryville Ca 94608.